Blog: MS news

PIPs: What next for benefit claimants?

31 January 2018

Source BBC:

BMSTC Member Sue Doughty is mentioned in the article - "Sue Doughty lives in Twyford, Berkshire. She has multiple sclerosis. She faced homelessness and had to rely on help from her daughter.

Following a year spent in appeal, the Court of Tribunal awarded Sue PIP ongoing for life."

NICE proposes rejecting five drugs for relapsing MS - MS Trust responds

31 January 2018

Source MS Trust:

NICE has recommended Extavia, but rejected Copaxone, Avonex, Betaferon, Plegridy and Rebif in its preliminary appraisal of MS drugs. The MS Trust has responded to NICE’s consultation in the strongest possible terms.

Men hold secret to protect women from multiple sclerosis

31 January 2018

Source EurekAlert:

Guardian molecule induced by testosterone reverses harmful immune response, eliminates disease symptoms in female mice.

Be kind to your mind

22 January 2018

Source MS Trust:

We often focus solely on our physical health but looking after our mental health is also vital to our sense of wellbeing. Jo Johnson, a consultant neuropsychologist with a special interest in MS, introduces practical steps you can take to improve and maintain your mental wellbeing.

Ocrelizumab licensed for people with early primary progressive MS in the UK

22 January 2018

Source MS Society:

Ocrelizumab has been approved as the first licensed treatment for some people with primary progressive MS in the UK.

Today is Festival of Sleep Day!

3 January 2018

Source MS Trust:

As today is Festival of Sleep Day, we're talking sleep and MS. Poor sleep is common in people with multiple sclerosis, with about 50% of people reported to experience some form of sleep disturbance.

Urine infections in MS – an integrated approach to prevention & treatment.

3 January 2018

Source Miranda's MS Blog:

Miranda is an MS Specialist Nurse based in Bedford, she writes a blog to share things she has found good, useful or positive within the MS community.

Veterinary Nurse with MS loses case for more help

3 January 2018

Source ITV Meridian News:

Multiple Sclerosis is a condition that affects more than 1100,000 people in the UK but the MS Society claims that it's becoming more difficult for sufferers to claim disability benefit.

The charity is highlighting the case of a trainee veterinary nurse from Dorset who's been turned down for extra cash under the new Personal Independence payment system. Richard Slee also talked to Genevieve Edwards of the MS Society....

Special Christmas Shopping Event in Reading

23 November 2017

Source Reading Borough Council

Once again, Reading Borough Council are hosting a Special Shopping Evening for older and those with disabilities.

Ozanimod Superior to Avonex in Treating Relapsing MS in Phase 3 Trials, Celgene Reports

23 November 2017

Source Multiple Sclerosis News Today:

Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated with ozanimod had lower relapse rates and fewer MRI brain lesions compared to those given a current first-line therapy, Avonex (interferon β-1a).

These results will be used to support a request for ozanimod’s approval as an MS therapy with the U.S. Food and Drug Administration (FDA), a filing known as a New Drug...

Pages

Category

Archive